Our Mission

Transforming everyday life into extraordinary ideas

The Canadian Longitudinal Study on Aging (CLSA) is a large, national, long-term study that will follow approximately 50,000 men and women between the ages of 45 and 85 for at least 20 years. The study will collect information on the changing biological, medical, psychological, social, lifestyle and economic aspects of people’s lives. These factors will be studied in order to understand how, individually and in combination, they have an impact in both maintaining health and in the development of disease and disability as people age. The CLSA will be one of the most comprehensive studies of its kind undertaken to date, not only in Canada but around the world. 
Dr. Parminder Raina (McMaster University, Hamilton) is the lead principal investigator of the CLSA. Dr. Christina Wolfson (McGill University, Montreal) and Dr. Susan Kirkland (Dalhousie University, Halifax) are co-principal investigators of the CLSA. Drs. Raina, Wolfson and Kirkland, along with a team of more than 160 investigators and collaborators from several Canadian universities, have participated in the development of this innovative, interdisciplinary study.
For more information, please contact us at info@clsa-elcv.ca.
51,352 Participants recruited


18 th

U.S. researcher to discuss effects of physical activity on older adults

The next presentation in the CLSA Webinar Series on December 9 will feature a researcher from the United States who studies the factors that influence physical activity and the effects of physical activity on various health outcomes.

27 th

Webinar will describe advances in fracture risk assessment tools

The creation of fracture risk assessment tools and how recent enhancements to them can be applied in clinical practice will be the focus of the next CLSA webinar on November 16.

28 th

Genetics of osteoporosis subject of Oct. 19 webinar

Understanding the genetics of osteoporosis will be the focus of the next CLSA webinar on Oct. 19.

Dr. Brent Richards, an endocrinologist and genetic epidemiologist at the Jewish General Hospital of McGill University, will describe recent advances in whole-genome sequencing programs, and genome-wide genotyping approaches that can lead to greater knowledge about how genetics can better understand the etiology of a disease.